The mission of the BRTI is to promote the health and quality of life of the peoples of Africa through research and training in the field of biomedicine. The institute emphasises the need to establish and maintain the highest levels of quality, professionalism, ethical standards and efficiency in its activities, and publishes these webpages in a spirit of openness and transparency.
Community-based research on HIV using critical skills in genomics, bioinformatics and data science.
Manicaland HIV Project
Multidisciplinary research that help us understand & respond to trends in the spread, impact & control of the HIV epidemic in Zimbabwe.
A cluster-randomised trial that aims to determine the impact of community-based integrated HIV and sexual and reproductive health services for youth on HIV and other health outcomes.
Trials of Excellence in Southern Africa (TESA) consortium which is a continuation of the TESA I. TESA I was founded by a group on 9 institutions from 6 different under the phase 1 EDCTP framework.
A multi-disciplinary project, led by the London School of Hygiene & Tropical Medicine, that is investigating the leading causes of fever in children and adults attending primary care health services and those admitted to district hospitals in Laos, Malawi, Mozambique, Myanmar and Zimbabwe.
Despite the intensified use of Insecticide Residual Spraying (IRS) and Insecticide Treated Nets, parts of Zimbabwe have been experiencing a dramatic rise in numbers of malaria cases.
Impaired linear growth (stunting), is one of the most common manifestations of vertically-acquired HIV which can adversely impact bone and muscle development and function, particularly during adolescence – a critical period of somatic growth.
Youth have the highest incidence of HIV in sub-Saharan Africa but the lowest rates of testing. The feasibility and acceptability of HIV self-testing in adolescents and young people (FAST) study will investigate whether self-testing using oral mucosal transudate tests could be a solution.
A multi-site, individually randomised, double-blinded, placebo-controlled clinical trial. The trial aims to assess whether adjuvant treatment with azithromycin results in improvement in lung function in HIV-positive children with chronic lung disease.